Spain Radiotherapy Market Report 2022 to 2030

Spain Radiotherapy Market Analysis

$ 3999

By 2030, it is anticipated that the Spain Radiotherapy Market will reach a value of $197 Mn from $133 Mn in 2022, growing at a CAGR of 5% during 2022-2030. The Radiotherapy Therapeutics Market in Spain is dominated by a few domestic players such as IBA Dosimetry Iberia, Oncovision, and Elekta Iberia. The radiotherapy market in Spain is segmented into different types, technologies, procedures, applications, and end-users. The major risk factors associated with awareness of radiotherapy shortage of skilled staff, government initiatives, and reimbursement policy. The demand for Spain Radiotherapy is increasing on account of the rise in cancer cases in the country.

ID: IN10ESPH043 CATEGORY: Pharmaceuticals GEOGRAPHY: Spain AUTHOR: Dr. Vishwa Modhia

Buy Now

Spain Radiotherapy Market Analysis Summary

By 2030, it is anticipated that the Spain Radiotherapy Market will reach a value of $197 Mn from $133 Mn in 2022, growing at a CAGR of 5% during 2022-30.

Spain is a high-income developed country located in Southwestern Europe. The coastlines include the Bay of Biscay, the Mediterranean Sea, and the Northern Atlantic Ocean. Cancer is Spain's second biggest cause of death, after only cardiovascular disease. However, all signs point to cancer taking the lead soon. According to the International Agency for Research on Cancer, there will be 282421 new cancer cases in Spain in 2020. The number of cancer deaths in Spain in 2020 was 113054.

In Spain, approximately 50.5% of new malignancies receive radiotherapy at least once during the disease. Reradiation therapy and non-melanoma skin cancer drive further demand for these services. Approximately 25-30% of cancer patients with an indication for radiotherapy do not receive it due to variables such as access, patient preference, physician familiarity with the treatment, and, most importantly, resource problems, all of which contribute to its underutilization. Spain’s government spent 10.7% of its GDP on healthcare in 2020.

Spain Radiotherapy Market Analysis

Market Dynamics

Market Growth Drivers Analysis

In Spain, health care is organised as a National Health System (NHS) [8], with universal, free coverage for all Spanish people. Cancer-related mortality and incidence are on the rise in Spain. Cancer's disease burden is expected to rise dramatically. Cancer has a 27.7 % chance of emerging before the age of 75. In Spain, the industrial sector is still well-known. These aspects could boost Spain's, Radiotherapy Market.

Market restraints

Healthcare implementation is not standard because each of Spain's 17 autonomous regions oversees various areas of healthcare delivery in their individual territories. Cigarette cessation (particularly among adolescents and women), increased access to genetic screening, and reduced treatment disparities are all critical and pressing future issues. Spain is extremely susceptible to pandemic-risk industries. Spain, with a population of 45 Mn people, requires around 280 MV units. In Spain, there are currently 250 MV units, 45 of which are more than ten years old and 22 of which are cobalt 60 machines. These factors may deter new entrants into the Spain Radiotherapy Market.

Competitive Landscape

Key Players

Elekta Iberia: Elekta is a Swedish company that provides radiation therapy and radiosurgery equipment and software. Elekta Iberia is the Spanish subsidiary of the company and provides sales, service, and support for its products in Spain.
Varian Medical Systems Iberica: Varian is an American company that produces medical devices and software for the treatment of cancer and other medical conditions. Varian Medical Systems
Iberica is the Spanish subsidiary of the company and provides sales, service, and support for its products in Spain.
IBA Dosimetry Iberia: IBA Dosimetry is a Belgian company that provides dosimetry solutions for radiation therapy. IBA Dosimetry Iberia is the Spanish subsidiary of the company and provides sales, service, and support for its products in Spain.
Oncovision: Oncovision is a Spanish company that develops and manufactures medical devices and software for the detection and treatment of cancer. The company provides solutions for radiotherapy planning and monitoring, as well as intraoperative radiation therapy.
ViewRay Technologies Spain: ViewRay is an American company that provides MR-guided radiation therapy systems.

Healthcare Policies and Reimbursement Scenarios

In Spain, radiotherapy is regulated and reimbursed by the Spanish National Health System (Sistema Nacional de Salud, SNS). The SNS provides reimbursement for a range of radiotherapy technologies, including intensity-modulated radiation therapy (IMRT) and stereotactic body radiation therapy (SBRT), among others. The regulation of radiotherapy in Spain is overseen by the Spanish Ministry of Health, which establishes guidelines and protocols for the use of radiotherapy in the treatment of cancer and other medical conditions.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Radiotherapy Segmentation

By Type (Revenue, USD Billion):

External Beam Radiation Therapy
Linear Accelerators
Compact Advanced Radiotherapy Systems
Cyberknife
Gamma Knife
?Tomotherapy
Proton Therapy
Cyclotron
?Synchrotron
Internal Beam Radiation Therapy
Brachytherapy
Seeds
Applicators and Afterloaders
Electronic Brachytherapy
Systemic Radiation Therapy
?Others

?By Technology (Revenue, USD Billion):

External Beam Radiotherapy
Intensity-Modulated Radiation Therapy (IMRT)
Image-Guided Radiation Therapy (IGRT)
Stereotactic Radiation Therapy (SRT)
3D Conformal Radiation Therapy (3D-CRT)
Particle Therapy
Internal Beam Radiotherapy
Brachytherapy
High-Dose Rate Brachytherapy
Low-Dose Rate Brachytherapy
Image-Guided Brachytherapy
Pulse-Dose Rate Brachytherapy
Systemic Radiation Therapy
Intravenous Radiotherapy
Oral Radiotherapy?

By Application (Revenue, USD Billion):

Breast Cancer
Cervical Cancer
Colon and rectum Cancers
Stomach Cancer
Lung Cancer
Prostate Cancer
Skin Cancer
Liver Cancer
Other types of cancer

By End User (Revenue, USD Billion):

Hospitals
Radiotherapy Centers & Ambulatory Surgery Centers
?Cancer Research Institutes

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.